(CIDRAP News) In its seventh annual report card on the nation's public health preparedness, the advocacy group Trust for America's Health (TFAH) praised the US response to the H1N1 influenza pandemic but also said it has exposed serious gaps in the ability to deal with public health emergencies.
(CIDRAP News) Sanofi has recalled four lots of its prefilled syringe pandemic vaccine for children ages 6 months through 35 months after its post-distribution monitoring found that antigen content dropped slightly below required levels, a problem that federal officials say isn't linked to any safety concerns.
As much as we'd all like to put behind us the tale of H1N1, the first influenza pandemic of this century, I'm afraid it's too soon to stamp the words "The End." What's more, I've reached a conclusion that the way we define severity—or lack thereof—is as antiquated as the egg technology we've used to produce a vaccine for 40-plus years.
(CIDRAP News) New ways of producing influenza vaccine that would free the process from long-standing problems are on the horizon, federal officials said today, but they added that scientific and regulatory hurdles will slow the products' movement past licensure and into the market.
(CIDRAP News) Another month's worth of data on H1N1 influenza has led federal officials to more than double their estimates of total cases, hospitalizations, and deaths and to assert that the impact on children and younger adults has been far greater than that of a typical flu season.